Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabrice Barlesi

Showing results (71-80 of 344) with videos related to

Pageof 35
Sort By:
Cancer|September 22, 2007
Accuracy of pleural biopsy using thoracoscopy for the diagnosis of histologic subtype in patients with malignant pleural mesotheliomaLaurent Greillier, Arnaud Cavailles, Anne Fraticelli, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|March 24, 2005
Does the extent of lymph node dissection influence outcome in patients with stage I non-small-cell lung cancer?Christophe Doddoli, Adrian Aragon, Fabrice Barlesi, et al.
Cancer Chemotherapy and Pharmacology|August 2, 2014
Metronomics chemotherapy: time for computational decision supportDominique Barbolosi, Joseph Ciccolini, Christophe Meille, et al.
Tumori|May 28, 2020
Real-world efficacy and safety of pembrolizumab in patients with non-small cell lung cancer: a retrospective observational studyFrançois Cavaille, Mathieu Peretti, Marie Eve Garcia, et al.
Cancer Cytopathology|September 5, 2020
Predictive molecular pathology in non-small cell lung cancer in France: The past, the present and the perspectivesPaul Hofman, Etienne Rouleau, Jean-Christophe Sabourin, et al.
JCO Global Oncology|March 14, 2024
Real-World Treatment Patterns and Clinical Outcomes After Platinum-Doublet Chemotherapy and Immunotherapy in Metastatic Non-Small Cell Lung Cancer: A Multiregional Chart Review in the United States, Europe, and JapanTiciana A Leal, Anandaroop Dasgupta, Dominick Latremouille-Viau, et al.
JCO Global Oncology|September 20, 2024
Real-World Outcomes of First-Line Treatment With Anti-PD(L)1-Based Combination Therapy for Nonsquamous Metastatic Non-Small Cell Lung Cancer: A Multiregional Chart Review in Europe, Japan, and the United StatesStephen V Liu, Anandaroop Dasgupta, Dominick Latremouille-Viau, et al.
Lung Cancer (Amsterdam, Netherlands)|May 29, 2026
First-line treatment patterns and real-world outcomes in patients with advanced KRAS-mutated non-small cell lung cancer with high unmet needFabrice Barlesi, Ferdinandos Skoulidis, Benjamin Solomon, et al.
Journal of Geriatric Oncology|March 3, 2019
Functional status in a geriatric oncology setting: A reviewAnne-Laure Couderc, Rabia Boulahssass, Emilie Nouguerède, et al.
Oncology and Therapy|April 5, 2026
Radiopharmaceutical Therapy in Oncology: Perspectives from Transatlantic ExpertsDésirée Deandreis, Heather Jacene, Patrick Therasse, et al.
Pageof 35

Showing results (71-80 of 344) with videos related to

Sort By:
Pageof 35
Cancer|September 22, 2007
Accuracy of pleural biopsy using thoracoscopy for the diagnosis of histologic subtype in patients with malignant pleural mesotheliomaLaurent Greillier, Arnaud Cavailles, Anne Fraticelli, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|March 24, 2005
Does the extent of lymph node dissection influence outcome in patients with stage I non-small-cell lung cancer?Christophe Doddoli, Adrian Aragon, Fabrice Barlesi, et al.
Cancer Chemotherapy and Pharmacology|August 2, 2014
Metronomics chemotherapy: time for computational decision supportDominique Barbolosi, Joseph Ciccolini, Christophe Meille, et al.
Tumori|May 28, 2020
Real-world efficacy and safety of pembrolizumab in patients with non-small cell lung cancer: a retrospective observational studyFrançois Cavaille, Mathieu Peretti, Marie Eve Garcia, et al.
Cancer Cytopathology|September 5, 2020
Predictive molecular pathology in non-small cell lung cancer in France: The past, the present and the perspectivesPaul Hofman, Etienne Rouleau, Jean-Christophe Sabourin, et al.
JCO Global Oncology|March 14, 2024
Real-World Treatment Patterns and Clinical Outcomes After Platinum-Doublet Chemotherapy and Immunotherapy in Metastatic Non-Small Cell Lung Cancer: A Multiregional Chart Review in the United States, Europe, and JapanTiciana A Leal, Anandaroop Dasgupta, Dominick Latremouille-Viau, et al.
JCO Global Oncology|September 20, 2024
Real-World Outcomes of First-Line Treatment With Anti-PD(L)1-Based Combination Therapy for Nonsquamous Metastatic Non-Small Cell Lung Cancer: A Multiregional Chart Review in Europe, Japan, and the United StatesStephen V Liu, Anandaroop Dasgupta, Dominick Latremouille-Viau, et al.
Lung Cancer (Amsterdam, Netherlands)|May 29, 2026
First-line treatment patterns and real-world outcomes in patients with advanced KRAS-mutated non-small cell lung cancer with high unmet needFabrice Barlesi, Ferdinandos Skoulidis, Benjamin Solomon, et al.
Journal of Geriatric Oncology|March 3, 2019
Functional status in a geriatric oncology setting: A reviewAnne-Laure Couderc, Rabia Boulahssass, Emilie Nouguerède, et al.
Oncology and Therapy|April 5, 2026
Radiopharmaceutical Therapy in Oncology: Perspectives from Transatlantic ExpertsDésirée Deandreis, Heather Jacene, Patrick Therasse, et al.
Pageof 35